Does uric acid-lowering treatment slow the progression of chronic kidney disease? A meta-analysis of randomized controlled trials Paulo Roberto Bignardi, Danielle Harumi Ido, Felipe Augusto Lopes Garcia, Lucas Mendes Braga, Vinicius Daher Alvares Delfino

Telomerase activity in patients with stage 2–5D chronic kidney disease Veysel Kidir, Ayse Aynali, Atila Altuntas, Salih Inal, Buket Aridogan, Mehmet Tugrul Sezer

Cardiovascular and renal outcomes according to KDIGO stages of chronic kidney disease in the Spanish population: Insights from real-world evidence Rafael Santamaria, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Ignacio Hernández, Ana Cebrián, Roberto Alcázar, Manuel Gorostidi